Australia's largest stock trading and investment forum Australia's #1 stock forum

UNS

0.00%

0.5¢ unilife corporation

Ann: Appendix 4D, page-32

First 32 Last

Share
Profile

Follow
cadrifter

1,247 Posts.

12/02/17

09:20

Post #: 22546616
Share

Originally posted by Swiss Gnome ↑

Hey Team,

Well in any case that has to be the most detailed honest cleansing report ever to come out of this enterprise.Really what to expect after years of mismanagement and virtually ZERO governance.
Its a miracle this company wasn't put some time ago in Chapter 11 with the cavalier type corporate behaviour & related party transactions accompanied.
Look even if there is yet another dilutive financing , which seems very much on the cards, it will mean survival & a way forwards. Better to own 1% of a sustainable business than 2% of nothing.
The statement below is encouraging & welcome news in what is still a very difficult & unpredictable time for the company.
Its very easy to understand the sell side sentiment & hugely tough to buy in now..but the potential upside from the "chump change" MCap of today is large if & when the company secure operating funds going forwards.

"Known trends in the industry that we believe will have a material favorable impact on our revenue include a shift in the focus of large pharmaceutical and biotechnology companies’ product development activities to biologic therapies, an emphasis within health-care providers to patient self-administration and a growing demand for passive safety for injectable drug delivery. There has been a marked shift in the product development activities of large customers toward biologic therapies, and the majority of therapies in the pipeline of large pharmaceutical and biotechnology companies are complex biologic therapies. The characteristics of many of these therapies (including, for example, large dose volumes and increased viscosity) necessitates administration by injection using innovative injectable drug delivery systems such as our products. We believe that we are well-positioned to meet what we expect to be a growing demand for innovative injectable drug delivery systems in light of the focus on biologic therapies. Concurrently with the shift toward biologic therapies is an emphasis towards patient self-administration. Patient self-administration is viewed as a growing trend in order to reduce demand pressure on the health-care system as well as reducing costs, especially for treatment of chronic illnesses. Devices suitable for self-administration of injectable therapies need to be safe and intuitive to use. We believe that our products are well suited for safe and intuitive patient self-administration of injectable therapies."

Now off for a game at the Wainui Club north of Auckland on a fresh breezy day.
Investing or rather speculating in Unilife has been like playing a golf course with nearly every hole against the wind...
Time to reach the down wind part of the course soon.

Best,
S.G

Expand

Hey S.G

If you combine that statement with this article ( http://www.biopharma-reporter.com/U...he-Biomanufacturing-investment-key-for-growth ) helps to support what management is telling us.

UNS Price at posting: 4.2¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

Dale Gillham's weekly wrap: picking resilient stocks in a volatile global market

TNC

True North increases silver metal at QLD's Vero deposit by 20%

EQN

Equinox plans mining campaign to test REE-hosting clays, sampling picks up 5,879 ppm in TREOs

NEU

Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress

Bitcoin: Current State of Play & Where to Next | Swyftx

TKM

Trek Metals jumps 5% as gold & REE drill run kicks off at Christmas Creek in the Kimberley

Emerald & Azure score Digger & Dealer awards

From the Floor with Federal Opposition Leader Peter Dutton at Diggers & Dealers 2024

Revolutionary inverter technology leads the clean energy charge

HZR

Hazer Group reports ten days of continuous operation at graphite-manufacturing test facility

There are more pages in this discussion • 3 more messages in this thread...

First 32 Last

Add UNS (ASX) to my watchlist

Ann: Appendix 4D, page-32

Top Stories

Dale Gillham's weekly wrap: picking resilient stocks in a volatile global market

True North increases silver metal at QLD's Vero deposit by 20%

Equinox plans mining campaign to test REE-hosting clays, sampling picks up 5,879 ppm in TREOs

Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress

Bitcoin: Current State of Play & Where to Next | Swyftx

Trek Metals jumps 5% as gold & REE drill run kicks off at Christmas Creek in the Kimberley

Emerald & Azure score Digger & Dealer awards

From the Floor with Federal Opposition Leader Peter Dutton at Diggers & Dealers 2024

Revolutionary inverter technology leads the clean energy charge

Hazer Group reports ten days of continuous operation at graphite-manufacturing test facility

Featured News